MVP and Vinorelbine for Malignant Pleural Mesothelioma

Lancet. 2008 Aug 23;372(9639):629; author reply 629-30. doi: 10.1016/S0140-6736(08)61273-8.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cisplatin / therapeutic use
  • Humans
  • Mesothelioma / drug therapy*
  • Mitomycins / therapeutic use
  • Pleural Neoplasms / drug therapy*
  • Randomized Controlled Trials as Topic
  • Research Design
  • Vinblastine / analogs & derivatives*
  • Vinblastine / therapeutic use
  • Vinorelbine

Substances

  • Antineoplastic Agents, Phytogenic
  • Mitomycins
  • Vinblastine
  • Cisplatin
  • Vinorelbine

Supplementary concepts

  • MVP protocol 2